Wireless Monitoring Facilitates Cardiac Patient Management

A new remote cardiac rhythm monitor incorporates complete mobile cardiac telemetry (MCT), Holter, and cellular event monitoring.

The 3-1 TeleSense device is a comfortable to wear, simple to set up, and configurable device for the auto-detection of arrhythmia events and concomitant wireless transmission of three-channel electrocardiogram (ECG) data, thus allowing clinicians to more accurately correlate between patient symptoms and changes in the electrical conduction of the heart. A web-accessible platform supports detailed and actionable reporting through daily event reports, heart rate trends reports, and end-of-session reports; interim and summary statistics; and advanced administrative and clinical queries.


The device can transmit up to 30 days of continuous ECG data across multiple cellular networks or by utilizing a patient’s own WiFi network. For clinicians unable to offer patients 24-hour monitoring coverage, an optional dedicated monitoring service provides active daily surveillance and reporting capabilities, as well as immediate access to raw data and completed reports from any internet connected computer. Optional electronic health record (EHR) integration enables reports to be easily viewed and e-signed by the physician prior to automated transmission.

Brightly-lit icons allow the patient to easily identify whether the device has sufficient power, whether leads are properly connected, if the device is recording, and the status of the WiFi or cellular connection. Patients can also quickly record and immediately transmit self-identified events via a large, easily accessible button on the front of the device, helping to address the continuous concern of patient compliance. The 3-1 TeleSense device is a product of ScottCare (Cleveland, OH, USA).

“We created TeleSense with the goal of providing clinicians with an easy-to-use, comprehensive monitoring device they could trust for diagnostic accuracy, technological reliability and improved patient compliance,” said Sneh Merchant, vice president of research and development at ScottCare. “They can depend on TeleSense to help them care for their cardiac event patients in a highly convenient and effective way.”

Related Links:
ScottCare